Quetiapine Fumarate
Product Images NDC 0406-1184

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 0406-1184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Que150mg60tablets (Que150mg60tablets)

Label for Quetiapine Fumarate Extended-Release Tablets USP 150 mg, 60 tablets per bottle. The label states the medication guide requirement, dosage form, and strength with the instruction "Once Daily". It includes manufacturer information (Intellipharmaceutics Corp, Toronto, ON) and distributor (SpecGx LLC, Webster Groves, MO). The label features a barcode and details on tablet composition and storage conditions.*

FDA Label Image

Que200mg60tablets (Que200mg60tablets)

Label for Quetiapine Fumarate Extended-Release Tablets USP, 200 mg strength, in a package of 60 tablets. The label includes dosing instructions of once daily and the proprietary name prominently displayed. The product is labeled Rx only and shows the labeler SpecGx LLC and manufacturer Intellipharmaceutics Corp, with distribution by Mallinckrodt Pharmaceuticals. The NDC is partially visible as 0406-1182-60.*

FDA Label Image

Que300mg60tablets (Que300mg60tablets)

Label for Quetiapine Fumarate Extended-Release Tablets USP, 300 mg strength, with a dosage of once daily. The label indicates a package containing 60 tablets and includes manufacturer and distributor information: Intellicorp Pharmaceuticals Corp. in Toronto, Canada, and SpecGx LLC in Webster Groves, MO. The label notes the tablet contains 345 mg quetiapine fumarate equivalent to 300 mg quetiapine and includes storage and dosage instructions. Mallinckrodt Pharmaceuticals branding is also present.*

FDA Label Image

Que400mg60tablets (Que400mg60tablets)

Label for Quetiapine Fumarate Extended-Release Tablets USP 400 mg, 60 tablets. The label states the dosage form as extended-release tablets with a strength of 400 mg taken once daily. It includes medication guide information, manufacturer Intellipharmaceutics Corp. (Toronto, Canada), and distributor SpecGx LLC (Webster Groves, MO). The label also features the Mallinckrodt Pharmaceuticals logo and a UPC barcode.*

FDA Label Image

Que50mg60tablets (Que50mg60tablets)

Label for Quetiapine Fumarate Extended-Release Tablets USP, 50 mg strength, 60 tablets per package. The label includes NDC 0406-1180-60, dosage instruction 'Once Daily', and states Rx only. It lists Intellipharmaceutics Corp. as the manufacturer in Toronto, Canada, and SpecGx LLC as the distributor in Webster Groves, Missouri. The label also displays Mallinckrodt Pharmaceuticals branding.*

FDA Label Image

Quefig1 (Quefig1)

A line graph showing the proportion of patients with relapse (%) over time (months) comparing two groups labeled PLA and QUE ER. The graph plots relapse rates from 0 to 7 months, with PLA showing a higher relapse proportion than QUE ER throughout the study period, illustrating a treatment comparison.*

FDA Label Image

Quefig2 (Quefig2)

A line graph showing the proportion of patients with relapse over time (in weeks) comparing Quetiapine plus Lithium/Valproate (QUE + LI/VAL) versus Placebo plus Lithium/Valproate (PLA + LI/VAL). The graph depicts relapse rates increasing over 100 weeks, with PLA + LI/VAL showing a higher relapse proportion than QUE + LI/VAL.*

FDA Label Image

Quefig3 (Quefig3)

A line graph depicting the proportion of patients with relapse (%) over time (weeks) for two groups: QUE + LI/VAL and PLA + LI/VAL. The x-axis represents time in weeks (0 to 100), and the y-axis shows the relapse percentage (0 to 100%). The QUE + LI/VAL group shows a consistently lower proportion of relapse compared to the PLA + LI/VAL group across the time period.*

FDA Label Image

Questructure (Questructure)

Chemical structure of Quetiapine Fumarate, showing the Quetiapine molecule linked to half a molecule of fumaric acid. The diagram includes the molecular arrangement of nitrogen, oxygen, sulfur atoms, and carbon rings characteristic of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.